{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T23:13:34Z","timestamp":1793747614396,"version":"4.6.1"},"reference-count":71,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100012524","name":"Nederlandse Federatie van Universitair Medische Centra","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012524","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Clinical Electrophysiology"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.jacep.2018.03.006","type":"journal-article","created":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T15:02:40Z","timestamp":1525273360000},"page":"569-579","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":326,"title":["Clinical Spectrum of SCN5A Mutations"],"prefix":"10.1016","volume":"4","author":[{"given":"Arthur A.M.","family":"Wilde","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad S.","family":"Amin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacep.2018.03.006_bib1","doi-asserted-by":"crossref","first-page":"4099","DOI":"10.1113\/jphysiol.2013.256461","article-title":"Cardiac sodium channelopathy associated with SCN5A mutations: electrophysiological, molecular and genetic aspects","volume":"591","author":"Remme","year":"2013","journal-title":"J\u00a0Physiol"},{"key":"10.1016\/j.jacep.2018.03.006_bib2","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.gene.2015.08.062","article-title":"The cardiac sodium channel gene SCN5A and its gene product NaV1.5: role in physiology and pathophysiology","volume":"573","author":"Veerman","year":"2015","journal-title":"Gene"},{"key":"10.1016\/j.jacep.2018.03.006_bib3","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1161\/CIRCRESAHA.116.305017","article-title":"Ion channel macromolecular complexes in cardiomyocytes: roles in sudden cardiac death","volume":"116","author":"Abriel","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.jacep.2018.03.006_bib4","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1253\/circj.CJ-14-0905","article-title":"Genetic and clinical advances in congenital long QT syndrome","volume":"78","author":"Mizusawa","year":"2014","journal-title":"Circ J"},{"key":"10.1016\/j.jacep.2018.03.006_bib5","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1056\/NEJM199810013391404","article-title":"Influence of genotype on the clinical course of the long-QT syndrome","volume":"339","author":"Zareba","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacep.2018.03.006_bib6","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1161\/01.CIR.103.1.89","article-title":"Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias","volume":"103","author":"Schwartz","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2018.03.006_bib7","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0735-1097(03)00554-0","article-title":"Modulating effects of age and gender on the clinical course of long QT syndrome by genotype","volume":"42","author":"Zareba","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacep.2018.03.006_bib8","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1172\/JCI0215928","article-title":"Insights into the molecular mechanisms of bradycardia-triggered arrhythmias in long QT-3 syndrome","volume":"110","author":"Clancy","year":"2002","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jacep.2018.03.006_bib9","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1161\/CIRCULATIONAHA.116.021823","article-title":"Clinical aspects of type 3 long-QT syndrome: an international multicenter study","volume":"134","author":"Wilde","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2018.03.006_bib10","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s10557-012-6433-x","article-title":"Late sodium current inhibition in acquired and inherited ventricular (dys)function and arrhythmias","volume":"27","author":"Remme","year":"2013","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.jacep.2018.03.006_bib11","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.jacc.2015.12.033","article-title":"Gene-specific therapy with mexiletine reduces arrhythmic events in patients with long QT syndrome type 3","volume":"67","author":"Mazzanti","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacep.2018.03.006_bib12","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.hrthm.2013.05.014","article-title":"HRS\/EHRA\/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013","volume":"10","author":"Priori","year":"2013","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacep.2018.03.006_bib13","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jelectrocard.2005.06.101","article-title":"Is it time to include ion channel diseases among cardiomyopathies?","volume":"38","author":"Corrado","year":"2005","journal-title":"J\u00a0Electrocardiol"},{"key":"10.1016\/j.jacep.2018.03.006_bib14","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1161\/CIRCEP.115.003366","article-title":"ST-segment elevation and fractionated electrograms in Brugada syndrome patients arise from the same structurally abnormal subepicardial RVOT area but have a different mechanism","volume":"8","author":"Ten Sande","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacep.2018.03.006_bib15","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1093\/eurheartj\/ehp252","article-title":"Magnetic resonance investigations in Brugada syndrome reveal unexpectedly high rate of structural abnormalities","volume":"30","author":"Catalano","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacep.2018.03.006_bib16","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1016\/j.hrthm.2010.09.004","article-title":"Spontaneous type 1 electrocardiographic pattern is associated with cardiovascular magnetic resonance imaging changes in Brugada syndrome","volume":"7","author":"Papavassiliu","year":"2010","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacep.2018.03.006_bib17","doi-asserted-by":"crossref","first-page":"e295","DOI":"10.1016\/j.hrthm.2016.05.024","article-title":"J-Wave syndromes, expert consensus conference report: emerging concepts and gaps in knowledge","volume":"13","author":"Antzelevitch","year":"2016","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacep.2018.03.006_bib18","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1093\/hmg\/ddv036","article-title":"Testing the burden of rare variation in arrhythmia-susceptibility genes provides new insights into molecular diagnosis for Brugada syndrome","volume":"24","author":"Le Scouarnec","year":"2015","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jacep.2018.03.006_bib19","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1161\/CIRCGENETICS.109.853374","article-title":"SCN5A mutations and the role of genetic background in the pathophysiology of Brugada syndrome","volume":"2","author":"Probst","year":"2009","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.jacep.2018.03.006_bib20","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1038\/ng.2712","article-title":"Common variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac death","volume":"45","author":"Bezzina","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.jacep.2018.03.006_bib21","unstructured":"Amin AS. Safe drug use and the Brugada syndrome. Available at: www.brugadadrugs.org. Accessed December 21, 2017."},{"key":"10.1016\/j.jacep.2018.03.006_bib22","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/nrcardio.2016.143","article-title":"Pathogenesis and management of Brugada syndrome","volume":"13","author":"Sieira","year":"2016","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jacep.2018.03.006_bib23","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.hrthm.2015.08.038","article-title":"Risk stratification in Brugada syndrome: clinical characteristics, electrocardiographic parameters, and auxiliary testing","volume":"13","author":"Adler","year":"2016","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacep.2018.03.006_bib24","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1161\/CIRCULATIONAHA.115.017885","article-title":"Programmed ventricular stimulation for risk stratification in the Brugada syndrome: a pooled analysis","volume":"133","author":"Sroubek","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2018.03.006_bib25","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1161\/CIRCULATIONAHA.110.972612","article-title":"Prevention of ventricular fibrillation episodes in Brugada syndrome by catheter ablation over the anterior right ventricular outflow tract epicardium","volume":"123","author":"Nademanee","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2018.03.006_bib26","doi-asserted-by":"crossref","first-page":"e005053","DOI":"10.1161\/CIRCEP.117.005053","article-title":"Electrical substrate elimination in 135 consecutive patients with Brugada syndrome","volume":"10","author":"Pappone","year":"2017","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacep.2018.03.006_bib27","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.116.004185","article-title":"Management of Brugada syndrome 2016: should all high risk patients receive an ICD? Alternatives to implantable cardiac defibrillator therapy for Brugada syndrome","volume":"9","author":"Belhassen","year":"2016","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacep.2018.03.006_bib28","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1161\/CIRCEP.109.862441","article-title":"Exercise-induced ECG changes in Brugada syndrome","volume":"2","author":"Amin","year":"2009","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacep.2018.03.006_bib29","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1093\/europace\/eut009","article-title":"Alcohol-induced ventricular fibrillation in a case of Brugada syndrome","volume":"15","author":"Ohkubo","year":"2013","journal-title":"Europace"},{"key":"10.1016\/j.jacep.2018.03.006_bib30","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1093\/eurheartj\/ehu301","article-title":"Atlas of the clinical genetics of human dilated cardiomyopathy","volume":"36","author":"Haas","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacep.2018.03.006_bib31","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1161\/01.CIR.0000144458.58660.BB","article-title":"SCN5A mutation associated with dilated cardiomyopathy, conduction disorder, and arrhythmia","volume":"110","author":"McNair","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2018.03.006_bib32","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1172\/JCI118445","article-title":"Mapping a cardiomyopathy locus to chromosome 3p22-p25","volume":"97","author":"Olson","year":"1996","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jacep.2018.03.006_bib33","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3389\/fphar.2015.00301","article-title":"Mutations in the voltage sensors of domains I and II of Nav1.5 that are associated with arrhythmias and dilated cardiomyopathy generate gating pore currents","volume":"6","author":"Moreau","year":"2015","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jacep.2018.03.006_bib34","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.hrthm.2014.05.031","article-title":"SCN5A-related dilated cardiomyopathy: what do we know?","volume":"11","author":"Amin","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacep.2018.03.006_bib35","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.cardiores.2007.04.009","article-title":"Dilated cardiomyopathy is associated with reduced expression of the cardiac sodium channel Scn5a","volume":"75","author":"Hesse","year":"2007","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacep.2018.03.006_bib36","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1161\/CIRCULATIONAHA.110.987248","article-title":"Striking In\u00a0vivo phenotype of a disease-associated human SCN5A mutation producing minimal changes in\u00a0vitro","volume":"124","author":"Watanabe","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2018.03.006_bib37","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jacc.2012.02.052","article-title":"Multifocal ectopic Purkinje-related premature contractions: a new SCN5A-related cardiac channelopathy","volume":"60","author":"Laurent","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacep.2018.03.006_bib38","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/j.jacc.2012.05.050","article-title":"R222Q SCN5A mutation is associated with reversible ventricular ectopy and dilated cardiomyopathy","volume":"60","author":"Mann","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacep.2018.03.006_bib39","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/j.hrthm.2014.04.042","article-title":"Novel SCN5A mutation in amiodarone-responsive multifocal ventricular ectopy-associated cardiomyopathy","volume":"11","author":"Beckermann","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacep.2018.03.006_bib40","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/12618","article-title":"Cardiac conduction defects associate with mutations in SCN5A","volume":"23","author":"Schott","year":"1999","journal-title":"Nat Genet"},{"key":"10.1016\/j.jacep.2018.03.006_bib41","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1161\/01.RES.0000069689.09869.A8","article-title":"Contribution of sodium channel mutations to bradycardia and sinus node dysfunction in LQT3 families","volume":"92","author":"Veldkamp","year":"2003","journal-title":"Circ Res"},{"key":"10.1016\/j.jacep.2018.03.006_bib42","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1016\/j.jacc.2005.08.043","article-title":"High risk for bradyarrhythmic complications in patients with Brugada syndrome caused by SCN5A gene mutations","volume":"46","author":"Makiyama","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacep.2018.03.006_bib43","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1172\/JCI200318062","article-title":"Congenital sick sinus syndrome caused by recessive mutations in the cardiac sodium channel gene (SCN5A)","volume":"112","author":"Benson","year":"2003","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jacep.2018.03.006_bib44","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.yjmcc.2005.02.024","article-title":"A\u00a0mutation in the human cardiac sodium channel (E161K) contributes to sick sinus syndrome, conduction disease and Brugada syndrome in two families","volume":"38","author":"Smits","year":"2005","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.jacep.2018.03.006_bib45","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1113\/jphysiol.2005.083188","article-title":"Sinus node dysfunction following targeted disruption of the murine cardiac sodium channel gene Scn5a","volume":"567","author":"Lei","year":"2005","journal-title":"J\u00a0Physiol"},{"key":"10.1016\/j.jacep.2018.03.006_bib46","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1111\/j.1540-8167.2005.50104.x","article-title":"Electrophysiological basis and genetics of Brugada syndrome","volume":"16","author":"Grant","year":"2005","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacep.2018.03.006_bib47","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1161\/01.RES.0000050585.07097.D7","article-title":"A\u00a0cardiac sodium channel mutation cosegregates with a rare connexin40 genotype in familial atrial standstill","volume":"92","author":"Groenewegen","year":"2003","journal-title":"Circ Res"},{"key":"10.1016\/j.jacep.2018.03.006_bib48","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1161\/CIRCULATIONAHA.107.757955","article-title":"Cardiac sodium channel (SCN5A) variants associated with atrial fibrillation","volume":"117","author":"Darbar","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2018.03.006_bib49","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.hrthm.2007.09.015","article-title":"Cardiac sodium channel mutation in atrial fibrillation","volume":"5","author":"Ellinor","year":"2008","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacep.2018.03.006_bib50","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/j.jacc.2008.07.013","article-title":"A\u00a0novel SCN5A gain-of-function mutation M1875T associated with familial atrial fibrillation","volume":"52","author":"Makiyama","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacep.2018.03.006_bib51","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.bbrc.2009.01.052","article-title":"Gain-of-function mutation of Nav1.5 in atrial fibrillation enhances cellular excitability and lowers the threshold for action potential firing","volume":"380","author":"Li","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jacep.2018.03.006_bib52","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.hrthm.2009.10.035","article-title":"Atrial electrophysiological and structural remodeling in high-risk patients with Brugada syndrome: assessment with electrophysiology and echocardiography","volume":"7","author":"Toh","year":"2010","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacep.2018.03.006_bib53","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1093\/europace\/eur011","article-title":"Facilitatory and inhibitory effects of SCN5A mutations on atrial fibrillation in Brugada syndrome","volume":"13","author":"Amin","year":"2011","journal-title":"Europace"},{"key":"10.1016\/j.jacep.2018.03.006_bib54","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/j.hrthm.2008.07.013","article-title":"A\u00a0mutation in the sodium channel is responsible for the association of long QT syndrome and familial atrial fibrillation","volume":"5","author":"Benito","year":"2008","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacep.2018.03.006_bib55","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1540-8167.2008.01339.x","article-title":"Atrial arrhythmias in long-QT syndrome under daily life conditions: a nested case control study","volume":"20","author":"Zellerhoff","year":"2009","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacep.2018.03.006_bib56","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1161\/CIRCEP.108.779181","article-title":"Mutations in sodium channel \u03b21- and \u03b22-subunits associated with atrial fibrillation","volume":"2","author":"Watanabe","year":"2009","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacep.2018.03.006_bib57","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1093\/cvr\/cvq348","article-title":"Mutations in sodium channel \u03b2-subunit SCN3B are associated with early-onset lone atrial fibrillation","volume":"89","author":"Olesen","year":"2011","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacep.2018.03.006_bib58","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.hrthm.2012.06.029","article-title":"Escape capture bigeminy: phenotypic marker of cardiac sodium channel voltage sensor mutation R222Q","volume":"9","author":"Nair","year":"2012","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacep.2018.03.006_bib59","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1161\/CIRCGENETICS.114.000703","article-title":"Gain-of-function mutation of the SCN5A gene causes exercise-induced polymorphic ventricular arrhythmias","volume":"7","author":"Swan","year":"2014","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.jacep.2018.03.006_bib60","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.RES.85.12.1206","article-title":"A\u00a0single Na+ channel mutation causing both long-QT and Brugada syndromes","volume":"85","author":"Bezzina","year":"1999","journal-title":"Circ Res"},{"key":"10.1016\/j.jacep.2018.03.006_bib61","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1046\/j.1540-8167.2001.00630.x","article-title":"Possible bradycardic mode of death and successful pacemaker treatment in a large family with features of long QT syndrome type 3 and Brugada syndrome","volume":"12","author":"van den Berg","year":"2001","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacep.2018.03.006_bib62","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1172\/JCI0215570","article-title":"Long QT syndrome, Brugada syndrome, and conduction system disease are linked to a single sodium channel mutation","volume":"110","author":"Grant","year":"2002","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jacep.2018.03.006_bib63","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1161\/01.CIR.102.9.945","article-title":"The elusive link between LQT3 and Brugada syndrome: the role of flecainide challenge","volume":"102","author":"Priori","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2018.03.006_bib64","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.hrthm.2004.07.001","article-title":"Novel pore mutation in SCN5A manifests as a spectrum of phenotypes ranging from atrial flutter, conduction disease, and Brugada syndrome to sudden cardiac death","volume":"1","author":"Rossenbacker","year":"2004","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacep.2018.03.006_bib65","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1093\/europace\/eun267","article-title":"SCN5A overlap syndromes: no end to disease complexity?","volume":"10","author":"Remme","year":"2008","journal-title":"Europace"},{"key":"10.1016\/j.jacep.2018.03.006_bib66","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1161\/hc5001.100834","article-title":"Novel SCN5A mutation leading either to isolated cardiac conduction defect or Brugada syndrome in a large French family","volume":"104","author":"Kyndt","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2018.03.006_bib67","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1002\/humu.9144","article-title":"Sodium channel gene (SCN5A) mutations in 44 index patients with Brugada syndrome: different incidences in familial and sporadic disease","volume":"21","author":"Schulze-Bahr","year":"2003","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jacep.2018.03.006_bib68","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0735-1097(02)01962-9","article-title":"Genotype-phenotype relationship in Brugada syndrome: electrocardiographic features differentiate SCN5A-related patients from non-SCN5A-related patients","volume":"40","author":"Smits","year":"2002","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacep.2018.03.006_bib69","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1161\/hc1002.105183","article-title":"Na+ channel mutation that causes both Brugada and long-QT syndrome phenotypes: a simulation study of mechanism","volume":"105","author":"Clancy","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2018.03.006_bib70","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1161\/CIRCULATIONAHA.106.653949","article-title":"Overlap syndrome of cardiac sodium channel disease in mice carrying the equivalent mutation of human SCN5A-1795insD","volume":"114","author":"Remme","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2018.03.006_bib71","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0735-1097(02)02864-4","article-title":"Haploinsufficiency in combination with aging causes SCN5A-linked hereditary Len\u00e8gre disease","volume":"41","author":"Probst","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"}],"container-title":["JACC: Clinical Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405500X18302081?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405500X18302081?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T07:25:12Z","timestamp":1762500312000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405500X18302081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":71,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S2405500X18302081"],"URL":"https:\/\/doi.org\/10.1016\/j.jacep.2018.03.006","relation":{},"ISSN":["2405-500X"],"issn-type":[{"value":"2405-500X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Spectrum of SCN5A Mutations","name":"articletitle","label":"Article Title"},{"value":"JACC: Clinical Electrophysiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacep.2018.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}